BC
OGN icon

Barrett & Company’s Organon & Co OGN Stock Holding History

Barrett & Company’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Buy
132
+17
+15% +$203 ﹤0.01% 632
2026
Q1 		$689 Sell
115
-6
-5% -$45 ﹤0.01% 621
2025
Q4 		$867 Hold
121
– – ﹤0.01% 622
2025
Q3 		$1.29K Sell
121
-14
-10% -$137 ﹤0.01% 601
2025
Q2 		$1.31K Sell
135
-32
-19% -$330 ﹤0.01% 600
2025
Q1 		$2.49K Sell
167
-21
-11% -$323 ﹤0.01% 544
2024
Q4 		$2.81K Sell
188
-4
-2% -$65 ﹤0.01% 534
2024
Q3 		$3.67K Sell
192
-48
-20% -$995 ﹤0.01% 507
2024
Q2 		$4.97K Sell
240
-28
-10% -$556 ﹤0.01% 489
2024
Q1 		$5.04K Sell
268
-50
-16% -$858 ﹤0.01% 489
2023
Q4 		$4.59K Sell
318
-59
-16% -$803 ﹤0.01% 478
2023
Q3 		$6.54K Sell
377
-3
-0.8% -$63 ﹤0.01% 459
2023
Q2 		$7.91K Sell
380
-26
-6% -$565 ﹤0.01% 430
2023
Q1 		$9.55K Sell
406
-54
-12% -$1.45K 0.01% 389
2022
Q4 		$12.8K Hold
460
– – 0.01% 361
2022
Q3 		$12.8K Buy
+460
New +$13.9K 0.01% 361

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Barrett & Company's OGN Position: Q2 2026 in Review

Barrett & Company increased its Organon & Co (OGN) stake by 15% in Q2 2026, buying an estimated $203 and bringing the position to 132 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Barrett & Company first reported a position in OGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $12.8K in Q4 2022. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Barrett & Company held 132 shares of Organon & Co worth $1.79K as of Q2 2026.
  • Barrett & Company bought 17 Organon & Co shares in Q2 2026, an estimated $203.
  • Organon & Co made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #632 holding.
  • Barrett & Company first reported a position in Organon & Co in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Organon & Co position peaked at $12.8K in Q4 2022.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.